Celgene | search
Click here to view Celgene news from 60+ newspapers.
Bookmark or Share- REMS PATIENT SAFETYTo avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs are mandatory for the REMS products THALOMID ® (thalidomide), POMALYST ® (pomalidomide), REVLIMID ® (lenalidomide) and generic lenalidomide. The THALOMID REMS ® program, Lenalidomide REMS program and POMALYST REMS ® program require prescribers and pharmacists to be certified and patients to enroll and ...
- Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a ...NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and ...
- Bristol-Myers Squibb to buy Celgene in $74 billion deal - CNNNew York CNN Business —. Drugmaker Bristol-Myers Squibb announced Thursday a $74 billion deal to buy Celgene, in one of the biggest mergers in pharmaceutical industry history. The deal, which ...
- Celgene | LinkedInCelgene | 275,655 followers on LinkedIn. We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines...
- Celgene: A Global Biopharmaceutical Company Committed to Improving the ...Learn how Celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by delivering truly innovative and life-changing treatments. Explore the therapies for Hematology, Oncology, Inflammation and Immunology and the medical research to help people live longer, better, and healthier.
More
